These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

106 related articles for article (PubMed ID: 3245761)

  • 1. The significance of the imidazole ring in anticonvulsant activity of (arylalkyl)imidazoles.
    Caliş U; Dalkara S; Ertan M; Sunal R
    Arch Pharm (Weinheim); 1988 Dec; 321(12):841-6. PubMed ID: 3245761
    [No Abstract]   [Full Text] [Related]  

  • 2. Structure-activity relationships of (arylalkyl)imidazole anticonvulsants: comparison of the (fluorenylalkyl)imidazoles with nafimidone and denzimol.
    Robertson DW; Krushinski JH; Beedle EE; Leander JD; Wong DT; Rathbun RC
    J Med Chem; 1986 Sep; 29(9):1577-86. PubMed ID: 3746810
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Nafimidone, an imidazole anticonvulsant, and its metabolite as potent inhibitors of microsomal metabolism of phenytoin and carbamazepine.
    Kapetanovic IM; Kupferberg HJ
    Drug Metab Dispos; 1984; 12(5):560-4. PubMed ID: 6149905
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Synthesis of some novel 1-(2-naphthyl)-2-(imidazol-1-yl)ethanone oxime ester derivatives and evaluation of their anticonvulsant activity.
    Karakurt A; Alagöz MA; Sayoğlu B; Calış U; Dalkara S
    Eur J Med Chem; 2012 Nov; 57():275-82. PubMed ID: 23085104
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Inhibition and induction of hepatic drug metabolism in rats and mice by nafimidone and its major metabolite nafimidone alcohol.
    Rush WR; Smith SA; Mulvey JH; Graham DJ; Chaplin MD
    Drug Metab Dispos; 1987; 15(4):571-8. PubMed ID: 2888633
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Inhibition of microsomal phenytoin metabolism by nafimidone and related imidazoles. Potency and structural considerations.
    Kapetanovic IM; Kupferberg HJ
    Drug Metab Dispos; 1985; 13(4):430-7. PubMed ID: 2863106
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Interaction of the anticonvulsants, denzimol and nafimidone, with liver cytochrome P450 in the rat.
    Salmona M; Conti I; Testa R; Fracasso C; Caccia S
    J Pharm Pharmacol; 1988 Jan; 40(1):17-21. PubMed ID: 2896768
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Synthesis, anticonvulsant and antimicrobial activities of some new 2-acetylnaphthalene derivatives.
    Karakurt A; Ozalp M; Işik S; Stables JP; Dalkara S
    Bioorg Med Chem; 2010 Apr; 18(8):2902-11. PubMed ID: 20363141
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Doses of radioprotective agents used in trials of radioprotection: apropos of imidazole and naphazoline].
    Caravel JP; Luu Duc C
    Farmaco Prat; 1981 Feb; 36(2):49-57. PubMed ID: 7215528
    [No Abstract]   [Full Text] [Related]  

  • 10. Simultaneous determination of nafimidone [1-(2-naphthoylmethyl)imidazole], a new anticonvulsant agent, and a major metabolite in plasma by high-performance liquid chromatography.
    Graham DJ; Eadie J; Leadbetter BM; Metcalf R
    J Chromatogr; 1983 Jun; 275(1):211-6. PubMed ID: 6409915
    [No Abstract]   [Full Text] [Related]  

  • 11. 1-(Naphthylalkyl)-1H-imidazole derivatives, a new class of anticonvulsant agents.
    Walker KA; Wallach MB; Hirschfeld DR
    J Med Chem; 1981 Jan; 24(1):67-74. PubMed ID: 7205879
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Synthesis and alpha-adrenergic activities of 2- and 4-substituted imidazoline and imidazole analogues.
    Amemiya Y; Hong SS; Venkataraman BV; Patil PN; Shams G; Romstedt K; Feller DR; Hsu FL; Miller DD
    J Med Chem; 1992 Feb; 35(4):750-5. PubMed ID: 1347319
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Synthesis and anticonvulsant evaluation of 1,2-diphenylethane derivatives, potential metabolites of denzimol.
    Catto A; Rossi A; Leonardi A; Testa R; Nardi D
    Farmaco; 1989 Jun; 44(6):595-607. PubMed ID: 2803448
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Synthesis and anticonvulsant activity of new thiazolidinone and thioxoimidazolidinone derivatives derived from furochromones.
    Ragab FA; Eid NM; el-Tawab HA
    Pharmazie; 1997 Dec; 52(12):926-9. PubMed ID: 9442556
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Compounds with potential antiparasitic action. V. Imidazole derivatives].
    Kadłubowski R; Wasiewicz P
    Wiad Parazytol; 1985; 31(1):69-73. PubMed ID: 4013339
    [No Abstract]   [Full Text] [Related]  

  • 16. [Durene derivates. IV. N-((2,3,5,6-tetramethylbenzoyl)alkyl)imidazoles and N-((beta-(2,3,5,6-tetramethylphenyl)-beta-hydroxy)ethyl)imidazoles with anticonvulsant activity].
    Leonardi A; Motta G; Subissi A; Nardi D
    Farmaco Sci; 1981 Aug; 36(8):711-20. PubMed ID: 7274447
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Imidazole anticonvulsants: structure-activity relationships of [(biphenylyloxy)alkyl]imidazoles.
    Robertson DW; Beedle EE; Lawson R; Leander JD
    J Med Chem; 1987 May; 30(5):939-43. PubMed ID: 3572983
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The metabolism of nafimidone hydrochloride in the dog, primates and man.
    Rush WR; Alexander OF; Hall DJ; Dow RJ; Tokes L; Kurz L; Graham DJ
    Xenobiotica; 1990 Jan; 20(1):123-32. PubMed ID: 2109431
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Derivatives of imidazole. II. Synthesis and reactions of imidazo[1,2-alpha]pyrimidines and other bi- and tricyclic imidazo derivatives with analgesic, antiinflammatory, antipyretic, and anticonvulsant activity.
    Almirante L; Polo L; Mugnaini A; Provinciali E; Rugarli P; Gamba A; Olivi A; Murmann W
    J Med Chem; 1966 Jan; 9(1):29-33. PubMed ID: 5958956
    [No Abstract]   [Full Text] [Related]  

  • 20. A study of the central effects of sympathomimetic drugs: EEG and behavioural investigations on clonidine and naphazoline.
    Florio V; Bianchi L; Lonogo VG
    Neuropharmacology; 1975 Oct; 14(10):707-14. PubMed ID: 637
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.